/PRNewswire/ Exact Sciences Corp. (Nasdaq: EXAS), a leader in advanced cancer diagnostics, today announced that company management will participate in the.
MADISON, Wis., May 2, 2022 /PRNewswire/ Exact Sciences Corp. , a leader in advanced cancer diagnostics, today announced that company management will participate in the following conference and. | May 2, 2022